Tropos OPI · Orbient Platform Intelligence
Tropos OPI is a One Health intelligence platform — fusing continuous environmental sensing, community disease surveillance, vector-borne and zoonotic risk signals, and domain-specific AI into a single architecture that predicts health risk before it becomes harm — across clinical, pharmaceutical, agricultural, maritime, and consumer settings.
The platform
Most environmental monitoring platforms are built for a single use case — a sensor for air quality, a dashboard for HVAC compliance, a wastewater feed for public health.
Tropos OPI is different. It is a single One Health intelligence architecture — continuous sensing infrastructure, a multi-domain AI fusion engine, and a compliance and governance layer — that deploys across every regulated environment that cares about what air, water, community burden, and ecological signals mean for the people inside.
The same platform that predicts CDI risk in an oncology unit powers Disease Weather's real-time pollen, air quality, and disease surveillance for consumers. Tropos Discovery — the platform's internal signal incubator — continuously surfaces emerging risk patterns across vector-borne disease, zoonotic spillover, wildfire toxin exposure, and coastal water risk, spinning each into a new product vertical.
Platform architecture
Vertical products
Each vertical is Tropos OPI configured for a specific regulated environment — its signals, its standards, its buyers.
Consumer & developer layer
Disease Weather is the public-facing layer of the Orbient platform and the world's first One Health consumer intelligence product. Free, real-time environmental health conditions for any US location — air quality, pollen, community disease burden, and environmental conditions fused into a single plain-English score. 877 monthly visitors across 10 countries. Zero marketing spend.
Disease Weather+ is the premium tier — adding a lifestyle survey, respiratory condition profile, and a personalized fourth domain that adjusts the Environmental Health Index to your specific vulnerability. Built for the 25+ million Americans living with asthma, COPD, pulmonary fibrosis, or immunocompromising conditions.
Open Disease Weather →Contact
Whether you are a hospital system, pharmaceutical manufacturer, investor, or researcher — we want to hear from you.